Oncolytic adenovirus H101 enhances the anti-tumor effects of PD-1 blockade via CD47 downregulation in tumor cells

The combination of H101 with PD-1 blockade exhibits potential as a novel strategy for the treatment of cancer.

Authors

Institutions

Publication Details

Journal
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Published
2024-12-11
DOI
https://doi.org/10.32604/or.2024.055746
Citations
6
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
3.30
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Oncolytic adenovirus H101 enhances the anti-tumor effects of PD-1 blockade via CD47 downregulation in tumor cells

Chenxiao Qiao, Yipeng Xu, Yedie He, Zhijian Cai et al.
6 citations
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
Virus-based gene therapy research
3.30
article

Oncolytic adenovirus H101 enhances the anti-tumor effects of PD-1 blockade via CD47 downregulation in tumor cells

Chenxiao Qiao, Yipeng Xu, Yedie He, Zhijian Cai, Hua Wang
article en
6 citations

Abstract

The combination of H101 with PD-1 blockade exhibits potential as a novel strategy for the treatment of cancer.

Oncology Research Featuring Preclinical and Clinical Cancer TherapeuticsVol. 33(5)
Zhejiang Cancer Hospital (CN), Zhejiang University (CN)
Good health and well-being
Openalex Percentile: Top 7%
Virus-based gene therapy research
3.30
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.